Display options
Share it on

Front Immunol. 2013 Mar 01;4:45. doi: 10.3389/fimmu.2013.00045. eCollection 2013.

NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury.

Frontiers in immunology

Nikolaos G Almyroudis, Melissa J Grimm, Bruce A Davidson, Marc Röhm, Constantin F Urban, Brahm H Segal

Affiliations

  1. Division of Infectious Diseases, Department of Medicine, University at Buffalo School of Medicine Buffalo, NY, USA ; Department of Medicine, Roswell Park Cancer Institute Buffalo, NY, USA.

PMID: 23459634 PMCID: PMC3585429 DOI: 10.3389/fimmu.2013.00045

Abstract

Neutrophils are armed with both oxidant-dependent and -independent pathways for killing pathogens. Activation of the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase constitutes an emergency response to infectious threat and results in the generation of antimicrobial reactive oxidants. In addition, NADPH oxidase activation in neutrophils is linked to activation of granular proteases and generation of neutrophil extracellular traps (NETs). NETosis involves the release of nuclear and granular components that can target extracellular pathogens. NETosis is activated during microbial threat and in certain conditions mimicking sepsis, and can result in both augmented host defense and inflammatory injury. In contrast, apoptosis, the physiological form of neutrophil death, not only leads to non-inflammatory cell death but also contributes to alleviate inflammation. Although there are significant gaps in knowledge regarding the specific contribution of NETs to host defense, we speculate that the coordinated activation of NADPH oxidase and NETosis maximizes microbial killing. Work in engineered mice and limited patient experience point to varying susceptibility of bacterial and fungal pathogens to NADPH oxidase versus NET constituents. Since reactive oxidants and NET constituents can injure host tissue, it is important that these pathways be tightly regulated. Recent work supports a role for NETosis in both acute lung injury and in autoimmunity. Knowledge gained about mechanisms that modulate NETosis may lead to novel therapeutic approaches to limit inflammation-associated injury.

Keywords: NADPH oxidase; NETs; inflammation; injury; neutrophils

References

  1. J Leukoc Biol. 2012 Mar;91(3):353-5 - PubMed
  2. J Clin Invest. 2012 Mar;122(3):787-95 - PubMed
  3. Am J Med. 1979 Jan;66(1):149-53 - PubMed
  4. Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5 - PubMed
  5. Infect Immun. 2011 Dec;79(12):4893-901 - PubMed
  6. Nature. 2002 Mar 21;416(6878):291-7 - PubMed
  7. Thromb Haemost. 2009 Aug;102(2):198-205 - PubMed
  8. J Exp Med. 2010 Aug 30;207(9):1853-62 - PubMed
  9. Cell. 2003 Nov 14;115(4):461-73 - PubMed
  10. Arthritis Rheum. 2005 Aug;52(8):2553-8 - PubMed
  11. Cell. 2008 Apr 18;133(2):235-49 - PubMed
  12. Am J Pathol. 2011 Jul;179(1):199-210 - PubMed
  13. PLoS Pathog. 2009 Oct;5(10):e1000639 - PubMed
  14. Blood. 2011 Apr 7;117(14):3881-92 - PubMed
  15. Nat Med. 2010 Aug;16(8):887-96 - PubMed
  16. Nat Med. 2011 Nov 07;17(11):1381-90 - PubMed
  17. J Exp Med. 1996 Aug 1;184(2):429-40 - PubMed
  18. Blood. 2011 Jun 2;117(22):5953-62 - PubMed
  19. Sci Transl Med. 2011 Mar 9;3(73):73ra20 - PubMed
  20. Proc Natl Acad Sci U S A. 2010 May 25;107(21):9813-8 - PubMed
  21. N Engl J Med. 2010 Dec 30;363(27):2600-10 - PubMed
  22. J Innate Immun. 2009;1(3):194-201 - PubMed
  23. Cell Host Microbe. 2012 Jul 19;12(1):109-16 - PubMed
  24. Infect Immun. 1974 Dec;10(6):1321-8 - PubMed
  25. Blood. 2011 Jan 20;117(3):953-9 - PubMed
  26. Blood. 2009 Sep 24;114(13):2619-22 - PubMed
  27. Medicine (Baltimore). 2000 May;79(3):155-69 - PubMed
  28. Biol Blood Marrow Transplant. 2011 Jan;17(1 Suppl):S123-31 - PubMed
  29. J Immunol. 2002 Apr 15;168(8):3974-82 - PubMed
  30. J Cell Biol. 2010 Nov 1;191(3):677-91 - PubMed
  31. J Exp Med. 1999 Oct 4;190(7):923-34 - PubMed
  32. PLoS One. 2011;6(12):e28149 - PubMed
  33. PLoS One. 2012;7(2):e32366 - PubMed
  34. Science. 2000 Aug 18;289(5482):1185-8 - PubMed
  35. J Leukoc Biol. 2000 May;67(5):662-8 - PubMed
  36. Cell Res. 2011 Feb;21(2):290-304 - PubMed
  37. J Immunol. 2013 Feb 15;190(4):1714-24 - PubMed
  38. Curr Opin Hematol. 2011 Jan;18(1):19-24 - PubMed
  39. Am J Physiol Lung Cell Mol Physiol. 2007 Mar;292(3):L760-8 - PubMed
  40. J Leukoc Biol. 2004 May;75(5):828-35 - PubMed
  41. Blood. 2012 Oct 11;120(15):3118-25 - PubMed
  42. J Biol Chem. 2011 Apr 8;286(14):12108-22 - PubMed
  43. J Biol Chem. 2004 Oct 15;279(42):44123-32 - PubMed
  44. J Immunol. 2008 Mar 1;180(5):3535-42 - PubMed
  45. FASEB J. 2002 Nov;16(13):1713-20 - PubMed
  46. Nature. 2011 Apr 28;472(7344):471-5 - PubMed
  47. Cell Death Differ. 2009 Nov;16(11):1438-44 - PubMed
  48. J Immunol. 1999 Jan 1;162(1):480-5 - PubMed
  49. J Immunol. 2011 Jul 1;187(1):538-52 - PubMed
  50. J Exp Med. 2010 Dec 20;207(13):2931-42 - PubMed
  51. Sci Transl Med. 2011 Mar 9;3(73):73ra19 - PubMed
  52. Science. 2004 Mar 5;303(5663):1532-5 - PubMed
  53. Immunity. 2005 Mar;22(3):285-94 - PubMed
  54. Immunity. 1996 Dec;5(6):653-66 - PubMed
  55. Nat Med. 2012 Sep;18(9):1386-93 - PubMed
  56. Infect Immun. 1974 Jan;9(1):48-52 - PubMed
  57. Blood. 1979 Mar;53(3):403-11 - PubMed
  58. J Immunol. 2009 Aug 15;183(4):2602-9 - PubMed
  59. J Immunol. 2004 Dec 15;173(12):7277-81 - PubMed
  60. Blood. 2008 Aug 15;112(4):1461-71 - PubMed
  61. J Clin Invest. 1989 Mar;83(3):865-75 - PubMed
  62. Immunity. 2002 Apr;16(4):547-58 - PubMed
  63. Immunity. 2005 Jun;22(6):679-91 - PubMed
  64. Cell Signal. 2001 May;13(5):335-43 - PubMed
  65. J Biol Chem. 2012 Dec 28;287(53):44603-18 - PubMed
  66. J Clin Invest. 2002 Feb;109(3):363-71 - PubMed
  67. J Clin Invest. 2008 Oct;118(10):3491-502 - PubMed
  68. Pediatrics. 2003 Jan;111(1):e85-8 - PubMed
  69. Cell Microbiol. 2010 Aug;12(8):1134-43 - PubMed
  70. J Immunol. 2012 Apr 1;188(7):3522-31 - PubMed
  71. J Cell Biol. 2009 Jan 26;184(2):205-13 - PubMed
  72. Nat Med. 2007 Apr;13(4):463-9 - PubMed
  73. Nature. 2002 May 2;417(6884):91-4 - PubMed
  74. Blood. 2011 Sep 29;118(13):3708-14 - PubMed
  75. J Clin Invest. 2012 Jul;122(7):2661-71 - PubMed
  76. Blood. 2012 Jun 28;119(26):6335-43 - PubMed
  77. J Clin Invest. 2001 Feb;107(4):419-30 - PubMed
  78. Am J Respir Crit Care Med. 2011 May 15;183(10):1391-401 - PubMed
  79. J Allergy Clin Immunol. 2011 May;127(5):1243-52.e7 - PubMed
  80. J Exp Med. 2007 Aug 6;204(8):1901-9 - PubMed
  81. Pediatrics. 2004 Aug;114(2):462-8 - PubMed
  82. J Immunol. 2012 Nov 1;189(9):4574-81 - PubMed
  83. Trends Immunol. 2009 Nov;30(11):538-46 - PubMed
  84. J Clin Invest. 2007 Nov;117(11):3445-52 - PubMed
  85. Nat Chem Biol. 2011 Feb;7(2):75-7 - PubMed
  86. J Infect Dis. 2011 Aug 15;204(4):592-600 - PubMed
  87. PLoS One. 2009;4(4):e5234 - PubMed
  88. J Cell Biol. 2007 Jan 15;176(2):231-41 - PubMed
  89. J Vis Exp. 2010 Feb 24;(36): - PubMed
  90. J Exp Med. 2003 May 5;197(9):1107-17 - PubMed
  91. Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13135-40 - PubMed
  92. Blood. 2008 Mar 15;111(6):2999-3004 - PubMed
  93. PLoS Pathog. 2011 Nov;7(11):e1002355 - PubMed
  94. Blood. 1999 Jan 15;93(2):674-85 - PubMed
  95. Nature. 2010 Mar 4;464(7285):104-7 - PubMed
  96. Cell Host Microbe. 2012 Sep 13;12(3):324-33 - PubMed
  97. Blood. 2010 Jul 29;116(4):625-7 - PubMed
  98. J Innate Immun. 2010;2(6):576-86 - PubMed

Publication Types

Grant support